Initial evaluation of an intracorporeal oxygenation device.
We describe a recently developed intracorporeal gas transfer device, its potential applications and hazards. To date, patients with potentially reversible respiratory failure have been treated with controlled oxygen therapy and positive pressure ventilation, but this treatment may itself contribute to lung parenchymal damage from barotrauma and oxygen toxicity. Total or partial extracorporeal gas exchange can be used to reduce these risks, but this treatment is complex and has significant morbidity and mortality. This gas exchange device has been designed to provide partial gas transfer with simplicity of insertion and use. The oxygenator lies in the vena cava to provide prepulmonary gas exchange. In preliminary studies with three calves we have shown that the device increases both mean mixed venous and arterial oxygen content and reduces mean arterial carbon dioxide tension.
Cockroft
S
S
Anaesthetics Unit, London Hospital Medical College.
Kuo
J
J
Colvin
M P
MP
Lewis
C T
CT
Innis
R F
RF
Withington
P S
PS
D000328:Adult; D000818:Animals; D001794:Blood Pressure / Q000502:physiology; D002245:Carbon Dioxide / Q000097:blood; D002417:Cattle; D005069:Evaluation Studies as Topic; D006801:Humans; D000860:Hypoxia / Q000503:physiopathology; D010100:Oxygen / Q000097:blood; D010106:Oxygenators / Q000592:standards*; D011651:Pulmonary Artery / Q000502:physiology
D002245:Carbon Dioxide; D010100:Oxygen